fonc.2016.00074

TRAF-6 Antibody (326019) [Alexa Fluor® 488] Summary

    Immunogen
    E.coli-derived recombinant human TRAF-6
    Met1-Val522
    Accession # Q9Y4K3
    Specificity
    Detects human TRAF-6 in direct ELISAs.
    Source
    N/A
    Isotype
    IgG2a
    Clonality
    Monoclonal
    Host
    Mouse
    Innovators Reward
    Test in a species/application not listed above to receive a full credit towards a future purchase.

    Learn about the Innovators Reward

Applications/Dilutions

    Dilutions
        Intracellular Staining by Flow Cytometry 0.25-1 ug/10^6 cells

Packaging, Storage & Formulations

    Storage
    Protect from light. Do not freeze.
    • 12 months from date of receipt, 2 to 8 °C as supplied.
    Buffer
    Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for TRAF-6 Antibody (326019) [Alexa Fluor® 488]

      E3 ubiquitin-protein ligase TRAF6
      EC 6.3.2.-
      Interleukin-1 signal transducer
      RING finger protein 85
      RNF85MGC:3310
      TNF receptor-associated factor 6
      TRAF6
      TRAF-6

Background

Tumor Necrosis Factor (TNF) Receptor-Associated Factors (TRAFs) are a family of adaptor proteins that interact with a wide range of cell surface receptors and participate in the regulation of cell survival, proliferation, differentiation, and stress response. TRAFs were identified by their ability to form complexes with TNF receptor superfamily members but more recently are reported to also bind to Toll/IL‑1 receptor family members and mediate cellular signaling. Six members of the TRAF family have been identified. All TRAF proteins have a homologous C-terminal TRAF domain that can bind the cytoplasmic domain of receptors as well as other TRAFs. TRAFs2-6 have N-terminal RING and zinc finger domains that are involved in signaling downstream events. TRAF-6 is a 522 amino acid, 60 kDa protein. Overexpression of TRAF-6 mediates the activation of NF-kappa-B and JNK signaling pathways. TRAF-3 and TRAF-6 have been identified as adaptor molecules involved in TLR/IL-1R signaling events.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

product targets : Notch inhibitors

Related Post